BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leucker TM, Osburn WO, Reventun P, Smith K, Claggett B, Kirwan BA, de Brouwer S, Williams MS, Gerstenblith G, Hager DN, Streiff MB, Solomon SD, Lowenstein CJ. Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial. JACC Basic Transl Sci 2021;6:935-45. [PMID: 34904132 DOI: 10.1016/j.jacbts.2021.09.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Bhatt AS, Daniels LB, de Lemos J, Goodrich E, Bohula EA, Morrow DA; AHA COVID-19 CVD Registry Investigators. Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry. Am Heart J 2023;258:149-56. [PMID: 36669711 DOI: 10.1016/j.ahj.2022.12.014] [Reference Citation Analysis]
2 Niculae C, Hristea A, Moroti R. Mechanisms of COVID-19 Associated Pulmonary Thrombosis: A Narrative Review. Biomedicines 2023;11:929. [DOI: 10.3390/biomedicines11030929] [Reference Citation Analysis]
3 Calderwood S, Sabir A, Rao L, Baker B, Balasa V, Sathi BK. SARS-CoV-2 Infection Presenting as Acute Chest Syndrome in a Child With Hemoglobin SD-Los Angeles Disease: A Case Report and Review of Literature. J Pediatr Hematol Oncol 2023;45:82-7. [PMID: 36162052 DOI: 10.1097/MPH.0000000000002546] [Reference Citation Analysis]
4 Chiang KC, Gupta A, Sundd P, Krishnamurti L. Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin. Biomedicines 2023;11. [PMID: 36830874 DOI: 10.3390/biomedicines11020338] [Reference Citation Analysis]
5 Ashton RE, Philips BE, Faghy M. The acute and chronic implications of the COVID-19 virus on the cardiovascular system in adults: A systematic review. Prog Cardiovasc Dis 2023;76:31-7. [PMID: 36690284 DOI: 10.1016/j.pcad.2023.01.003] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Christian J, Lanzkron S, Naik RP. COVID-19 outcomes in sickle cell disease and sickle cell trait. Best Pract Res Clin Haematol 2022;35:101382. [PMID: 36494153 DOI: 10.1016/j.beha.2022.101382] [Reference Citation Analysis]
7 Izzo R, Trimarco V, Mone P, Aloè T, Capra Marzani M, Diana A, Fazio G, Mallardo M, Maniscalco M, Marazzi G, Messina N, Mininni S, Mussi C, Pelaia G, Pennisi A, Santus P, Scarpelli F, Tursi F, Zanforlin A, Santulli G, Trimarco B. Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey. Pharmacol Res 2022;183:106360. [PMID: 35868478 DOI: 10.1016/j.phrs.2022.106360] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 17.0] [Reference Citation Analysis]
8 McCarthy MW. Novel Strategies for the Treatment of COVID-19. Drugs R D 2022. [PMID: 35999352 DOI: 10.1007/s40268-022-00400-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Rossouw TM, Anderson R, Manga P, Feldman C. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury. Front Immunol 2022;13:776861. [DOI: 10.3389/fimmu.2022.776861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]